253 related articles for article (PubMed ID: 12403983)
1. Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches.
Thoenen H; Sendtner M
Nat Neurosci; 2002 Nov; 5 Suppl():1046-50. PubMed ID: 12403983
[TBL] [Abstract][Full Text] [Related]
2. Exploratory clinical testing of neuroscience drugs.
Choi DW
Nat Neurosci; 2002 Nov; 5 Suppl():1023-5. PubMed ID: 12403975
[No Abstract] [Full Text] [Related]
3. [Neuronal growth factors--neurotrophins].
Meyer M; Rasmussen JZ
Ugeskr Laeger; 1999 Apr; 161(14):2063-70. PubMed ID: 10354791
[TBL] [Abstract][Full Text] [Related]
4. Neurotrophic molecules: strategies for designing effective therapeutic molecules in neurodegeneration.
Skaper SD; Walsh FS
Mol Cell Neurosci; 1998 Nov; 12(4-5):179-93. PubMed ID: 9828084
[TBL] [Abstract][Full Text] [Related]
5. [Neurotrophic factors: basis for their clinical application].
Morís G; Vega JA
Neurologia; 2003; 18(1):18-28. PubMed ID: 12590377
[TBL] [Abstract][Full Text] [Related]
6. From chemical to drug: neurodegeneration drug screening and the ethics of clinical trials.
Heemskerk J; Tobin AJ; Ravina B
Nat Neurosci; 2002 Nov; 5 Suppl():1027-9. PubMed ID: 12403977
[No Abstract] [Full Text] [Related]
7. [Treatment of peripheral neuropathies with neutrotrophic factors: animal models and clinical trials].
Pradat PF
Rev Neurol (Paris); 2003 Feb; 159(2):147-61. PubMed ID: 12660566
[TBL] [Abstract][Full Text] [Related]
8. [Use of chlorophyllypt for treating neurotoxoplasmosis].
Metaksa GIu; Primachenko NB
Vrach Delo; 1979 Jul; (7):111-3. PubMed ID: 224602
[No Abstract] [Full Text] [Related]
9. Central nervous system drug development, basic, and clinical research: thinking outside the box.
Klein DF; Glick ID; Shader RI
J Clin Psychopharmacol; 2011 Oct; 31(5):553-4. PubMed ID: 21869701
[No Abstract] [Full Text] [Related]
10. [Neuropathic pain].
Bach FW; Finnerup NS; Jensen TS
Ugeskr Laeger; 2006 May; 168(20):1964-6. PubMed ID: 16768895
[TBL] [Abstract][Full Text] [Related]
11. Advances in small molecules promoting neurotrophic function.
Price RD; Milne SA; Sharkey J; Matsuoka N
Pharmacol Ther; 2007 Aug; 115(2):292-306. PubMed ID: 17599430
[TBL] [Abstract][Full Text] [Related]
12. Neurotrophins in allergic diseases: from neuronal growth factors to intercellular signaling molecules.
Nockher WA; Renz H
J Allergy Clin Immunol; 2006 Mar; 117(3):583-9. PubMed ID: 16522457
[TBL] [Abstract][Full Text] [Related]
13. Set back for nerve growth factor.
Cadman J
GMHC Treat Issues; 1998 Sep; 12(9):12. PubMed ID: 11365804
[TBL] [Abstract][Full Text] [Related]
14. Nerve growth factor and chronic daily headache: a potential implication for therapy.
Sarchielli P; Gallai V
Expert Rev Neurother; 2004 Jan; 4(1):115-27. PubMed ID: 15853622
[TBL] [Abstract][Full Text] [Related]
15. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
16. Hand and foot pain study.
Treat Rev; 1997 Apr; (No 24):6. PubMed ID: 11364286
[TBL] [Abstract][Full Text] [Related]
17. Taxonomy and mechanisms of neuropathic pain.
Elliott KJ
Semin Neurol; 1994 Sep; 14(3):195-205. PubMed ID: 7701120
[No Abstract] [Full Text] [Related]
18. Miracles and molecules--progress in spinal cord repair.
Blight AR
Nat Neurosci; 2002 Nov; 5 Suppl():1051-4. PubMed ID: 12403984
[TBL] [Abstract][Full Text] [Related]
19. Growth factor treatment of neurodegenerative disorders: new developments pave the way for clinical success.
Rosenblad C
IDrugs; 2004 Mar; 7(3):243-8. PubMed ID: 15011099
[TBL] [Abstract][Full Text] [Related]
20. [The molecular mechanism of signal transduction of neurotrophins and apoptosis of neurocyte].
Luo X; Mao M
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Oct; 24(5):1187-90. PubMed ID: 18027724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
